Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies
US9766253B2 · kind B2 · utility
0Cited by
0References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 28, 2013 |
| Grant date | Sep 19, 2017 |
| Priority date | — |
| Expiry date | Jun 28, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the diagnosis of acquired sensory neuronopathies (SNN), and to the treatment of these disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.